{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:09:29Z","timestamp":1789009769331,"version":"build-2803163510"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T00:00:00Z","timestamp":1677542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T00:00:00Z","timestamp":1677542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1038\/s41409-023-01946-0","type":"journal-article","created":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T18:05:02Z","timestamp":1677607502000},"page":"567-580","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["SARS-CoV-2-reactive antibody waning, booster effect and breakthrough SARS-CoV-2 infection in hematopoietic stem cell transplant and cell therapy recipients at one year after vaccination"],"prefix":"10.1038","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8533-2562","authenticated-orcid":false,"given":"Jos\u00e9 Luis","family":"Pi\u00f1ana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5143-4042","authenticated-orcid":false,"given":"Rodrigo","family":"Martino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8191-0046","authenticated-orcid":false,"given":"Lourdes","family":"Vazquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"L\u00f3pez-Corral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariadna","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6741-971X","authenticated-orcid":false,"given":"Pedro","family":"Chor\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Avenda\u00f1o-Pita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda-Jes\u00fas","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"S\u00e1nchez-Salinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Sanz-Linares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda T.","family":"Olave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Arroyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9622-1649","authenticated-orcid":false,"given":"Mar","family":"Tormo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Villalon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6412-3419","authenticated-orcid":false,"given":"Venancio","family":"Conesa-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Gago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda-Jos\u00e9","family":"Terol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Villalba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4752-0815","authenticated-orcid":false,"given":"Valent\u00edn","family":"Garcia-Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almudena","family":"Cabero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 \u00c1ngel","family":"Hern\u00e1ndez-Rivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2994-9055","authenticated-orcid":false,"given":"Irene","family":"Garc\u00eda-Cadenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1559-7607","authenticated-orcid":false,"given":"Anabel","family":"Teruel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3010-4110","authenticated-orcid":false,"given":"David","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngel","family":"Cedillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Sureda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3702-0817","authenticated-orcid":false,"given":"Carlos","family":"Solano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH-TC)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,28]]},"reference":[{"key":"1946_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40164-020-00177-z","volume":"9","author":"JL Pi\u00f1ana","year":"2020","unstructured":"Pi\u00f1ana JL, Martino R, Garc\u00eda-Garc\u00eda I, Parody R, Morales MD, Benzo G, et al. Risk factors and outcome of COVID-19 in patients with hematological malignancies. Exp Hematol Oncol. 2020;9:21 https:\/\/doi.org\/10.1186\/s40164-020-00177-z","journal-title":"Exp Hematol Oncol"},{"key":"1946_CR2","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1038\/s41375-021-01302-5","volume":"35","author":"P Ljungman","year":"2021","unstructured":"Ljungman P, de la Camara R, Mikulska M, Tridello G, Aguado B, Zahrani MA, et al. COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey. Leukemia. 2021;35:2885\u201394. https:\/\/doi.org\/10.1038\/s41375-021-01302-5","journal-title":"Leukemia"},{"key":"1946_CR3","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.1038\/s41375-021-01466-0","volume":"35","author":"AM Spanjaart","year":"2021","unstructured":"Spanjaart AM, Ljungman P, de La Camara R, Tridello G, Ortiz-Maldonado V, Urbano-Ispizua A, et al. Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group. Leukemia. 2021;35:3585\u20138. https:\/\/doi.org\/10.1038\/s41375-021-01466-0","journal-title":"Leukemia"},{"key":"1946_CR4","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/ajh.26385","volume":"97","author":"JL Pi\u00f1ana","year":"2022","unstructured":"Pi\u00f1ana JL, L\u00f3pez-Corral L, Martino R, Montoro J, Vazquez L, P\u00e9rez A, et al. SARS-CoV-2-reactive antibody detection after SARS-CoV-2 vaccination in hematopoietic stem cell transplant recipients: Prospective survey from the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group. Am J Hematol. 2022;97:30\u201342. https:\/\/doi.org\/10.1002\/ajh.26385","journal-title":"Am J Hematol"},{"key":"1946_CR5","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13045-022-01275-7","volume":"15","author":"JL Pi\u00f1ana","year":"2022","unstructured":"Pi\u00f1ana JL, L\u00f3pez-Corral L, Martino R, Vazquez L, P\u00e9rez A, Martin-Martin G, et al. SARS-CoV-2 vaccine response and rate of breakthrough infection in patients with hematological disorders. J Hematol Oncol. 2022;15:54 https:\/\/doi.org\/10.1186\/s13045-022-01275-7. Infectious Complications Subcommittee of the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH-TC)","journal-title":"J Hematol Oncol"},{"key":"1946_CR6","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1182\/blood.2022016147","volume":"140","author":"CU Niemann","year":"2022","unstructured":"Niemann CU, da Cunha-Bang C, Helleberg M, Ostrowski SR, Brieghel C. Patients with CLL have a lower risk of death from COVID-19 in the Omicron era. Blood. 2022;140:445\u201350. https:\/\/doi.org\/10.1182\/blood.2022016147","journal-title":"Blood"},{"key":"1946_CR7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13045-022-01250-2","volume":"15","author":"M Leclerc","year":"2022","unstructured":"Leclerc M, Redjoul R, Le Bouter A, Beckerich F, Robin C, Parinet V, et al. Determinants of SARS-CoV-2 waning immunity in allogeneic hematopoietic stem cell transplant recipients. J Hematol Oncol. 2022;15:27 https:\/\/doi.org\/10.1186\/s13045-022-01250-2","journal-title":"J Hematol Oncol"},{"key":"1946_CR8","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/s41586-022-04399-5","volume":"602","author":"JM Carre\u00f1o","year":"2022","unstructured":"Carre\u00f1o JM, Alshammary H, Tcheou J, Singh G, Raskin AJ, Kawabata H, et al. Activity of convalescent and vaccine serum against SARS-CoV-2 omicron. Nature. 2022;602:682\u20138. https:\/\/doi.org\/10.1038\/s41586-022-04399-5","journal-title":"Nature"},{"key":"1946_CR9","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1056\/NEJMc2119358","volume":"386","author":"I Nemet","year":"2022","unstructured":"Nemet I, Kliker L, Lustig Y, Zuckerman N, Erster O, Cohen C, et al. Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron Infection. N. Engl J Med. 2022;386:492\u20134. https:\/\/doi.org\/10.1056\/NEJMc2119358","journal-title":"N. Engl J Med"},{"key":"1946_CR10","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1093\/infdis\/jiab569","volume":"225","author":"AY Collier","year":"2022","unstructured":"Collier AY, Yu J, McMahan K, Liu J, Atyeo C, Ansel JL, et al. Coronavirus Disease 2019 Messenger RNA Vaccine Immunogenicity in Immunosuppressed Individuals. J Infect Dis. 2022;225:1124\u20138. https:\/\/doi.org\/10.1093\/infdis\/jiab569","journal-title":"J Infect Dis"},{"key":"1946_CR11","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1038\/s41375-022-01578-1","volume":"36","author":"S Cesaro","year":"2022","unstructured":"Cesaro S, Ljungman P, Mikulska M, Hirsch HH, von Lilienfeld-Toal M, Cordonnier C, et al. Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on Infections in Leukaemia (ECIL 9). Leukemia. 2022;36:1467\u201380. https:\/\/doi.org\/10.1038\/s41375-022-01578-1","journal-title":"Leukemia"},{"issue":"Sep","key":"1946_CR12","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1007\/s00277-022-04906-8","volume":"101","author":"JL Pi\u00f1ana","year":"2022","unstructured":"Pi\u00f1ana JL, Rodr\u00edguez-Belenguer P, Caballero D, Martino R, Lopez-Corral L, Terol MJ, et al. Applicability of probabilistic graphical models for early detection of SARS-CoV-2 reactive antibodies after SARS-CoV-2 vaccination in hematological patients. Ann Hematol. 2022;101(Sep):2053\u201367. https:\/\/doi.org\/10.1007\/s00277-022-04906-8","journal-title":"Ann Hematol"},{"key":"1946_CR13","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1080\/10428194.2021.1992619","volume":"63","author":"JL Pi\u00f1ana","year":"2022","unstructured":"Pi\u00f1ana JL, V\u00e1zquez L, Martino R, de la C\u00e1mara R, Sureda A, Rodr\u00edguez-Veiga R, et al. Spanish Society of Hematology and Hemotherapy expert consensus opinion for SARS-CoV-2 vaccination in onco-hematological patients. Leuk Lymphoma. 2022;63:538\u201350. https:\/\/doi.org\/10.1080\/10428194.2021.1992619","journal-title":"Leuk Lymphoma"},{"key":"1946_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-022-00778-3","volume":"13","author":"JL Pi\u00f1ana","year":"2023","unstructured":"Pi\u00f1ana JL, Vazquez L, Calabuig M, L\u00f3pez-Corral L, Martin-Martin G, Villalon L, et al. One-year breakthrough SARS-CoV-2 infection and correlates of protection in fully vaccinated hematological patients. Blood Cancer J. 2023;13:8 https:\/\/doi.org\/10.1038\/s41408-022-00778-3. Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH-TC)","journal-title":"Blood Cancer J"},{"key":"1946_CR15","unstructured":"https:\/\/www.sanidad.gob.es\/profesionales\/saludPublica\/ccayes\/alertasActual\/nCov\/documentos\/COVID19_Actualizacion_variantes_20220523.pdf"},{"key":"1946_CR16","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O","volume":"18","author":"TA Gooley","year":"1999","unstructured":"Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999;18:695\u2013706. 10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O","journal-title":"Stat Med"},{"key":"1946_CR17","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144.","volume":"94","author":"JP Fine","year":"2012","unstructured":"Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 2012;94:496\u2013509. https:\/\/doi.org\/10.1080\/01621459.1999.10474144","journal-title":"J Am Stat Assoc"},{"key":"1946_CR18","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1214\/aos\/1176350951","volume":"16","author":"RJ Gray","year":"1988","unstructured":"Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat. 1988;16:1141\u201354. https:\/\/doi.org\/10.1214\/aos\/1176350951","journal-title":"Ann Stat"},{"key":"1946_CR19","doi-asserted-by":"publisher","first-page":"e2204336119","DOI":"10.1073\/pnas.2204336119","volume":"119","author":"JP Townsend","year":"2022","unstructured":"Townsend JP, Hassler HB, Sah P, Galvani AP, Dornburg A. The durability of natural infection and vaccine-induced immunity against future infection by SARS-CoV-2. Proc Natl Acad Sci. 2022;119:e2204336119 https:\/\/doi.org\/10.1073\/pnas.2204336119. Epub 2022 Jul 15","journal-title":"Proc Natl Acad Sci."},{"key":"1946_CR20","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1056\/NEJMc2032195","volume":"384","author":"AT Widge","year":"2021","unstructured":"Widge AT, Rouphael NG, Jackson LA, Anderson EJ, Roberts PC, Makhene M, et al. Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination. N. Engl J Med. 2021;384:80\u201382. https:\/\/doi.org\/10.1056\/NEJMc2032195. mRNA-1273 Study Group","journal-title":"N. Engl J Med"},{"key":"1946_CR21","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1056\/NEJMc2103916","volume":"384","author":"N Doria-Rose","year":"2021","unstructured":"Doria-Rose N, Suthar MS, Makowski M, O\u2019Connell S, McDermott AB, Flach B, et al. Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19. N. Engl J Med. 2021;384:2259\u201361. https:\/\/doi.org\/10.1056\/NEJMc2103916. mRNA-1273 Study Group","journal-title":"N. Engl J Med"},{"key":"1946_CR22","doi-asserted-by":"publisher","first-page":"214.e1","DOI":"10.1016\/j.jtct.2022.01.019","volume":"28","author":"A Huang","year":"2022","unstructured":"Huang A, Cicin-Sain C, Pasin C, Epp S, Audig\u00e9 A, M\u00fcller NJ, et al. Antibody Response to SARS-CoV-2 Vaccination in Patients following Allogeneic Hematopoietic Cell Transplantation. Transpl Cell Ther. 2022;28:214.e1\u2013214.e11. https:\/\/doi.org\/10.1016\/j.jtct.2022.01.019","journal-title":"Transpl Cell Ther"},{"key":"1946_CR23","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.cell.2022.01.011","volume":"185","author":"AC Walls","year":"2022","unstructured":"Walls AC, Sprouse KR, Bowen JE, Joshi A, Franko N, Navarro MJ, et al. SARS-CoV-2 breakthrough infections elicit potent, broad, and durable neutralizing antibody responses. Cell 2022;185:872\u2013880.e3. https:\/\/doi.org\/10.1016\/j.cell.2022.01.011","journal-title":"Cell"},{"key":"1946_CR24","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1056\/NEJMoa2203965","volume":"387","author":"HN Altarawneh","year":"2022","unstructured":"Altarawneh HN, Chemaitelly H, Ayoub HH, Tang P, Hasan MR, Yassine HM, et al. Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections. N. Engl J Med. 2022;387:21\u201334. https:\/\/doi.org\/10.1056\/NEJMoa2203965","journal-title":"N. Engl J Med"},{"key":"1946_CR25","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1056\/NEJMoa2118946","volume":"386","author":"Y Goldberg","year":"2022","unstructured":"Goldberg Y, Mandel M, Bar-On YM, Bodenheimer O, Freedman LS, Ash N, et al. Protection and Waning of Natural and Hybrid Immunity to SARS-CoV-2. N. Engl J Med. 2022;386:2201\u201312. https:\/\/doi.org\/10.1056\/NEJMoa2118946","journal-title":"N. Engl J Med"},{"key":"1946_CR26","doi-asserted-by":"publisher","unstructured":"Kimura M, Ferreira VH, Kothari S, Pasic I, Mattsson JI, Kulasingam V, et al. Safety and Immunogenicity After a Three-Dose SARS-CoV-2 Vaccine Schedule in Allogeneic Stem Cell Transplant Recipients. Transplant Cell Ther. 2022 Jul:S2666-6367(22)01510-X. https:\/\/doi.org\/10.1016\/j.jtct.2022.07.024","DOI":"10.1016\/j.jtct.2022.07.024"},{"key":"1946_CR27","doi-asserted-by":"publisher","first-page":"e681","DOI":"10.1016\/S2352-3026(21)00274-X","volume":"8","author":"R Redjoul","year":"2021","unstructured":"Redjoul R, Le Bouter A, Parinet V, Fourati S, Maury S. Antibody response after third BNT162b2 dose in recipients of allogeneic HSCT. Lancet Haematol. 2021;8:e681\u2013e683. https:\/\/doi.org\/10.1016\/S2352-3026(21)00274-X","journal-title":"Lancet Haematol"},{"key":"1946_CR28","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.3390\/v14091928","volume":"14","author":"A Ahmed-Belkacem","year":"2022","unstructured":"Ahmed-Belkacem A, Redjoul R, Brillet R, Ahnou N, Leclerc M, L\u00f3pez-Molina DS, et al. Third Early \u201cBooster\u201d Dose Strategy in France of bnt162b2 SARS-CoV-2 Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients Enhances Neutralizing Antibody Responses. Viruses. 2022;14:1928 https:\/\/doi.org\/10.3390\/v14091928","journal-title":"Viruses"},{"key":"1946_CR29","doi-asserted-by":"publisher","first-page":"e583","DOI":"10.1016\/S2352-3026(21)00169-1","volume":"8","author":"K Maneikis","year":"2021","unstructured":"Maneikis K, \u0160ablauskas K, Ringelevi\u010di\u016bt\u0117 U, Vaitek\u0117nait\u0117 V, \u010cekauskien\u0117 R, Kry\u017eauskait\u0117 L, et al. Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study. Lancet Haematol. 2021;8:e583\u2013e592. https:\/\/doi.org\/10.1016\/S2352-3026(21)00169-1","journal-title":"Lancet Haematol"},{"key":"1946_CR30","doi-asserted-by":"publisher","unstructured":"Uyemura BS, Abid MA, Suelzer E, Abid MB Efficacy of SARS-CoV-2 primary and booster vaccine doses in CAR-T recipients - targeting the target antigen. Bone Marrow Transplant. 2022 Aug:1\u20135. https:\/\/doi.org\/10.1038\/s41409-022-01795-3","DOI":"10.1038\/s41409-022-01795-3"},{"key":"1946_CR31","doi-asserted-by":"publisher","unstructured":"Jian F, Yu Y, Song W, Yisimayi A, Yu L, Gao Y, et al. Further humoral immunity evasion of emerging SARS-CoV-2 BA.4 and BA.5 subvariants. Lancet Infect Dis. 2022 Sep. https:\/\/doi.org\/10.1016\/S1473-3099(22)00642-9","DOI":"10.1016\/S1473-3099(22)00642-9"},{"key":"1946_CR32","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1182\/blood.2021013768","volume":"139","author":"M Mittelman","year":"2022","unstructured":"Mittelman M, Magen O, Barda N, Dagan N, Oster HS, Leader A, et al. Effectiveness of the BNT162b2mRNA COVID-19 vaccine in patients with hematological neoplasms in a nationwide mass vaccination setting. Blood. 2022;139:1439\u201351. https:\/\/doi.org\/10.1182\/blood.2021013768","journal-title":"Blood"},{"key":"1946_CR33","doi-asserted-by":"publisher","unstructured":"La J, Wu JT, Branch-Elliman W, Huhmann L, Han SS, Brophy MT, et al. Increased COVID-19 Breakthrough Infection Risk in Patients with Plasma Cell Disorders. Blood. 2022 May:blood.2022016317. https:\/\/doi.org\/10.1182\/blood.2022016317","DOI":"10.1182\/blood.2022016317"},{"key":"1946_CR34","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1182\/bloodadvances.2021006101","volume":"6","author":"M Jim\u00e9nez","year":"2022","unstructured":"Jim\u00e9nez M, Rold\u00e1n E, Fern\u00e1ndez-Naval C, Villacampa G, Martinez-Gallo M, Medina-Gil D, et al. Cellular and humoral immunogenicity of the mRNA-1273 SARS-CoV-2 vaccine in patients with hematologic malignancies. Blood Adv. 2022;6:774\u201384. https:\/\/doi.org\/10.1182\/bloodadvances.2021006101","journal-title":"Blood Adv"},{"key":"1946_CR35","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/s41586-020-03041-6","volume":"590","author":"K McMahan","year":"2021","unstructured":"McMahan K, Yu J, Mercado NB, Loos C, Tostanoski LH, Chandrashekar A, et al. Correlates of protection against SARS-CoV-2 in rhesus macaques. Nature. 2021;590:630\u20134. https:\/\/doi.org\/10.1038\/s41586-020-03041-6","journal-title":"Nature"},{"key":"1946_CR36","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1126\/science.abm3425","volume":"375","author":"PB Gilbert","year":"2022","unstructured":"Gilbert PB, Montefiori DC, McDermott AB, Fong Y, Benkeser D, Deng W, et al. Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial. Science. 2022;375:43\u201350. https:\/\/doi.org\/10.1126\/science.abm3425","journal-title":"Science"},{"key":"1946_CR37","doi-asserted-by":"publisher","unstructured":"Fong Y, McDermott AB, Benkeser D, Roels S, Stieh DJ, Vandebosch A, et al. Immune Assays Team; the Coronavirus Vaccine Prevention Network (CoVPN)\/ENSEMBLE Team; and the United States Government (USG)\/CoVPN Biostatistics Team. Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial. Nat Microbiol. 2022;7:1996\u20132010. https:\/\/doi.org\/10.1038\/s41564-022-01262-1","DOI":"10.1038\/s41564-022-01262-1"},{"key":"1946_CR38","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1016\/S0140-6736(22)00327-0","volume":"399","author":"C Menni","year":"2022","unstructured":"Menni C, Valdes AM, Polidori L, Antonelli M, Penamakuri S, Nogal A, et al. Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study. Lancet. 2022;399:1618\u201324. https:\/\/doi.org\/10.1016\/S0140-6736(22)00327-0","journal-title":"Lancet."},{"key":"1946_CR39","doi-asserted-by":"publisher","first-page":"e0048221","DOI":"10.1128\/jcm.00482-21","volume":"60","author":"A Misra","year":"2022","unstructured":"Misra A, Theel ES. Immunity to SARS-CoV-2: what do we know and should we be testing for it? J Clin Microbiol. 2022;60:e0048221.","journal-title":"J Clin Microbiol"},{"key":"1946_CR40","doi-asserted-by":"publisher","first-page":"e03149","DOI":"10.1128\/JCM.03149-20","volume":"59","author":"V Higgins","year":"2021","unstructured":"Higgins V, Fabros A, Kulasingam V. Quantitative measurement of anti-SARS-CoV-2 antibodies: analytical and clinical evaluation. J Clin Microbiol. 2021;59:e03149.","journal-title":"J Clin Microbiol"},{"key":"1946_CR41","first-page":"e017462","volume":"60","author":"K Saker","year":"2021","unstructured":"Saker K, Escuret V, Pitiot V, Massardier-Pilonch\u00e9ry A, Paul S, Mokdad B, et al. Evaluation of commercial anti-SARS-CoV-2 antibody assays and comparison of standardized titers in vaccinated healthcare workers. J Clin Microbiol. 2021;60:e017462.","journal-title":"J Clin Microbiol"},{"key":"1946_CR42","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.3390\/diagnostics12061426","volume":"12","author":"J Swad\u017aba","year":"2022","unstructured":"Swad\u017aba J, Anyszek T, Panek A, Choj\u0119ta A, Wyrzykowska K, Martin E. Head-to-head comparison of 5 anti-SARS-CoV-2 assays performance in one hundred COVID-19 vaccinees, over an 8-month course. Diagnostics. 2022;12:1426.","journal-title":"Diagnostics."},{"key":"1946_CR43","doi-asserted-by":"publisher","first-page":"335","DOI":"10.5937\/jomb0-31475","volume":"40","author":"E Danese","year":"2021","unstructured":"Danese E, Montagnana M, Salvagno G, Gelati M, Peserico D, Pighi L, et al. Comparison of five commercial anti-SARS- CoV-2 total antibodies and IgG immunoassays after vaccination with BNT162b2 mRNA. J Med Biochem. 2021;40:335\u201340.","journal-title":"J Med Biochem"},{"key":"1946_CR44","doi-asserted-by":"publisher","first-page":"e28397","DOI":"10.1002\/jmv.28397","volume":"95","author":"J Camacho","year":"2023","unstructured":"Camacho J, Albert E, Zulaica J, \u00c1lvarez-Rodr\u00edguez B, Rusu L, Olea B, et al. A performance comparison of two (electro) chemiluminescence immunoassays for detection and quantitation of serum anti-spike antibodies according to SARS-CoV-2 vaccination and infections status. J Med Virol. 2023;95:e28397.","journal-title":"J Med Virol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41409-023-01946-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-023-01946-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-023-01946-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T09:04:21Z","timestamp":1683277461000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-023-01946-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,28]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["1946"],"URL":"https:\/\/doi.org\/10.1038\/s41409-023-01946-0","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,28]]},"assertion":[{"value":"8 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The local Research Ethics Committee of the Hospital Cl\u00ednico Universitario of Valencia approved the registry and study protocol (reference code 35.21)","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All patients included in this registry gave their signed informed consent in accordance with the declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}